Clin Exp Dermatol
November 2024
Background: Trials evaluating the effectiveness of topical treatments for actinic cheilitis (AC) are scarce. Despite no comparative data, phenol-croton peeling has been reported as effective in treating this condition.
Methods: An open, randomized trial was conducted to compare the effectiveness and tolerability of 1.
An Bras Dermatol
August 2024
Background: 5-Fluorouracil (5-FU) is a first-line drug to treat cutaneous field cancerization (CFC). There are few clinical trials with topical colchicine (COL).
Objective: To evaluate the effectiveness of 0.
Background: Actinic keratosis (AK) is a skin condition associated with age, sun exposure, and immunosuppression. Certain drugs, such as photosensitizing medications and calcium channel blockers (CCBs), have been linked to AK. This study explores the impact of individual, behavioral, and exposure factors on the severity of AKs on the face and scalp.
View Article and Find Full Text PDFBackground: Thalidomide is the drug of choice for the treatment of type 2 leprosy reactions and is often associated with corticosteroids. The use of these drugs in multiple myeloma is associated with the risk of cardiovascular events, but there have been few studies assessing this risk in leprosy patients.
Objective: To evaluate the occurrence of cardiovascular events in patients with multibacillary leprosy and their correlation with the use of thalidomide and prednisone.
An Bras Dermatol
May 2022
An Bras Dermatol
March 2022
Background: Several treatments are available for skin with advanced photodamage, which is characterized by the presence of actinic keratoses (AK).
Objectives: Evaluate the efficacy of using sunscreen with photolyase compared to regular sunscreen, as well as to compare the combination of a topical formulation of antioxidants versus placebo in the treatment of advanced photodamage.
Methods: This was a randomized, double-blind, factorial clinical trial.
Indian J Dermatol Venereol Leprol
November 2021